Today’s guest post comes from Carl Schmid, Deputy Executive Director of the AIDS Institute.
The AIDS Institute studied health plans in Florida and uncovered a troubling reality: Patients are often unable to find out if their plan has a copay accumulator adjustment program.
Even when the information was somehow available, it was vague and ambiguous.
The AIDS Institute’s research shows how unsuspecting patients can get stuck with exorbitant out-of-pocket expenses for specialty drugs that have no generic or therapeutic alternatives. That’s why I told CNBC this week that accumulators are “as much of a cash grab from patients as I can possibly imagine.”
It’s an important article about the misleading marketing and incomplete disclosure of a crucial benefit detail. Read on and see what you think.
Read more »
Source: Post feed
